Mucosal-associated invariant T cells in hepatitis B virus-related liver failure

Figure 4 Partial recovery of circulating mucosal-associated invariant T cells in survived hepatitis B virus-related liver failure patients. A, B: The percentage (A) and count (B) of circulating mucosal-associated invariant T (MAIT) cells before and after treatment of surviving patients (n = 13) with hepatitis B virus (HBV)-related liver failure, and in healthy controls (HC) (n = 40); C, D: The percentage (C) and number (D) of MAIT cells in patients (n = 5) who died or underwent liver transplantation in HBV-related liver failure before and after conservative treatment. ^bP < 0.01, ^dP < 0.0001. NS: No significance; PBMC: Peripheral blood mononuclear cell.